Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4003)
All Articles published online
|
Publishing Process of This Article
|
Nov 6, 2022 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang JL, Xiang BX, Song XL, Que RM, Zuo XC, Xie YL. Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: A meta-analysis. World J Clin Cases 2022; 10(31): 11466-11485 [PMID: 36387815 DOI: 10.12998/wjcc.v10.i31.11466] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i31/11466.htm |
| Number | Citing Articles |
| 1 |
Fatma Nisa Ballı, Pınar Bakır Ekinci, Melek Kurtaran, Emre Kara, Gülçin Telli Dizman, Meliha Çağla Sönmezer, Mutlu Hayran, Kutay Demirkan, Gökhan Metan. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin. International Journal of Antimicrobial Agents 2024; 63(2): 107035 doi: 10.1016/j.ijantimicag.2023.107035
|
| 2 |
Tingting Liu, Jing Zhou, Xuejiao Liu, Xiaolu Xu. Comparative study of colistin methanesulfonate and colistin sulfate/polymyxin B in the treatment of ceftazidime-avibactam resistant Gram-negative bacilli infections. Intelligent Pharmacy 2024; 2(5): 715 doi: 10.1016/j.ipha.2024.01.004
|
| 3 |
Wei Li, Yu Liu, Lu Xiao, Xuezhou Cai, Weixi Gao, Dong Xu, Shishi Han, Yan He. Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1409998
|
| 4 |
Camila L P A M Bezerra, Eusébio L dos Santos, Maura S Oliveira, Maria Beatriz S Dias, Anna S Levin, Maristela P Freire, Icaro Boszczowski, Matias C Salomão. Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort. Clinical Infectious Diseases 2023; 77(Supplement_1): S62 doi: 10.1093/cid/ciad272
|
| 5 |
Qin‐jie Yang, Bi‐xiao Xiang, Mong‐hsiu Song, Chien‐yi Yang, Jun‐hao Liang, Yue‐liang Xie, Xiao‐cong Zuo. Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: A real‐world, retrospective cohort study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024; 44(8): 631 doi: 10.1002/phar.4601
|
| 6 |
Jingqian Su, Shun Wu, Fen Zhou, Zhiyong Tong. Research Progress of Macromolecules in the Prevention and Treatment of Sepsis. International Journal of Molecular Sciences 2023; 24(16): 13017 doi: 10.3390/ijms241613017
|
| 7 |
Pınar AYSERT-YILDIZ, Özge ÖZGEN-TOP, Ahmet Furkan ŞENTÜRK, Sait KANIK, Hasan Selçuk ÖZGER, Murat DİZBAY. Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09759-2
|
| 8 |
Yuanbing Wu, Shanshan Jiang, Dongyang Li, Yaxue Wu, Qian Li, Xing Wang, Bin Liu, Haiyan Bao, Depei Wu, Xiaohui Hu. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases. Infectious Diseases and Therapy 2024; 13(1): 141 doi: 10.1007/s40121-023-00909-8
|